Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Financials · ·
$374.62
▼ $4.87 (-1.3%)
Market data updated: 09/19 05:17 AM
Fundamentals updated: 09/19/2026
News analyzed: 09/19/2026
Market Cap
$78.14B
Day Range
$372.84 - $376.95
52-Week Range
$252.26 - $398.70
Beta
—
Next Earnings
16.10.2026
Support
$325.39
Resistance
$398.70
TRV is a stock from the Financials sector — Banks, insurance, and asset management — profitability sensitive to interest rates and credit cycles.
+34.8% (1Y)
Strengths: 17/25 factors positiveRisk: Low
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟢 Bullish
Technical Trend
🟢 Bullish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Earnings per share (EPS) growth
Earnings per share (EPS) growth: 27.8%
Growth
Biggest negative driver
Return on assets (ROA)
Return on assets (ROA): 4.4% — weak
Fundamental
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
71
Today
—
30D
—
90D
—
1Y
🕰️ Signal Timeline
What StockIQ actually saw for this stock, and what happened after each signal — real data, not a forecast.
3d ago · $378.05
Evidence: FOMO score jumped from 10 to 35 day-over-day
What happened after
Still awaiting outcome
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🕰️ StockIQ Time Machine
What did StockIQ know — and when? Pick a date from the real accumulated history.
As of September 19, 2026
Then
71
$374.62
Now
71
$374.62
What happened since
Signals detected by this date
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
68
Quality
55
Value
55
Momentum
87
Risk
72
Sentiment
100
Fundamental
57
Institutional
0
Stocks with a similar DNA right now
SCANNING TRV...
Recent media coverage of Travelers Companies has focused on its stock performance, underwriting improvements, and competitive positioning in the insurance sector. Analysts note the company’s outperformance in the S&P 500 while highlighting cautious optimism due to market competition, particularly in personal auto insurance. Reports also mention Travelers’ enhanced underwriting profitability, though some downgraded its stock to "hold" due to valuation concerns. Additionally, insider activity—such as the Chief Risk Officer selling shares—was briefly noted.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Travelers Companies (The). News trend score: 100. Reason: 18 of the last 20 articles are positive, versus 0 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
29
🎯 Conviction (vs. Emotion)
40
Psychology
38
Fundamentals
57
Technical
87
Valuation
55
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
The price rise has far outpaced the actual improvement in fundamental data.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Price (3M)
+22%
Market Narrative
68
Fundamental Reality
40
Narrative Gap
+28
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market’s dominant anchoring behavior suggests traders are fixating on the 1.7% support level, likely due to its proximity to recent price action. Herding and euphoria scores, while elevated, are muted by weak momentum and modest overvaluation, indicating cautious optimism rather than blind following. The narrative gap (64 vs. 40) hints at a disconnect where optimism may outpace tangible fundamentals. The key question: will traders break free from the support anchor, or will the stock consolidate around this level?
Updated: 09/09/2026, 09:26 AM
What could change this?
👥 What the crowd believes
"Better Underwriting"
"Chief Risk Officer Sells 6,000 Shares"
"favoring insurers like TRV"
"analysts are cautious about the stock’s prospects"
🧠 Market Brain events driving this
📈 9D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Morgan Housel — 85/100
🔴 Weakest match
Benjamin Graham (Enterprising Investor) — 21/100
🗣️ Why do they disagree?
The methodologies for TRV split sharply between those emphasizing growth potential and those skeptical of its valuation or market positioning. Lynch, Housel, and Loeb all see strong upside—Lynch highlights undervalued growth, Housel praises it as a patient-friendly compounder, and Loeb approves its capital-preservation traits—while Nelson and Smith lean toward cyclical or long-term buy-and-hold logic. Conversely, Fisher and Graham’s Enterprising Investor framework dismiss it outright, citing a lack of signature quality or statistical cheapness, while Marks’ cycle analysis flags it as late-stage, raising caution. The divide between bullish growth-oriented models and bearish valuation/cycle frameworks underscores whether TRV’s fundamentals justify its price or if it’s already priced for perfection.
Walter Bagehot
Lombard Street (1873)
🟢 100
Not enough balance-sheet data for a real Bagehot read
Key question
Does this company have enough liquidity to survive real stress?
⚠️ Partial data for this stock — score is less reliable — Data availability: 25%
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟢 85
The kind of quiet compounder a patient holder could actually stick with
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟢 84
Growth candidate — the price hasn't caught up to the growth
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟢 80
Reasonable capital-preservation profile
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 75
Looks like a real 'buy and hold for a decade' candidate
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟢 69
Growth appears aligned with real value creation
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 64
Mixed — doesn't clearly pass Graham's tests
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 56
No clear trend — Livermore preferred to stay out of this
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 54
Mixed — a good business, but expectations may already be high
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟡 50
Some signs of crowd excitement building
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 41
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 39
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟡 36
Cycle looks stretched toward overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 29
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
⚠️ Partial data for this stock — score is less reliable — Data availability: 35%
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🔴 25
No real setup here — the discipline Schwager's wizards shared would say stay out
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 21
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Based on the last 280 trading days, calculated from real price data. Click an indicator for details and a chart.
🟢 Most indicators support an uptrend (9 bullish · 0 bearish · 3 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear uptrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
—
Operating Margin
—
Net Margin
12.9%
EBITDA Margin
—
ROE
19.1%
ROA
4.4%
ROIC
—
EPS
$27.83
Cash
$842.00M
Total Debt
$300.00M
Current Ratio
—
Debt/Equity
0.01
אין נתונים היסטוריים זמינים.
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 10.9.2026 | $1.250 |
| 10.6.2026 | $1.250 |
| 9.6.2026 | $1.250 |
| 10.3.2026 | $1.100 |
| 9.3.2026 | $1.100 |
| 10.12.2025 | $1.100 |
| 9.12.2025 | $1.100 |
| 10.9.2025 | $1.100 |
| 9.9.2025 | $1.100 |
| 10.6.2025 | $1.100 |
| 9.6.2025 | $1.100 |
| 10.3.2025 | $1.050 |
How is Fair Value calculated? →
Not enough cash-flow data to calculate a DCF model for this stock.
Book Value per Share
$144.53
Tangible Book Value per Share (Tangible NAV)
$125.18
Sentiment based on basic keywords (not AI) — 18 positive, 2 neutral, 0 negative out of the last 20 articles.
ChartMill · 18.9.2026
ChartMill · 18.9.2026
Yahoo · 18.9.2026
Yahoo · 18.9.2026
Yahoo · 18.9.2026
ChartMill · 17.9.2026
Yahoo · 17.9.2026
ChartMill · 17.9.2026
Yahoo · 17.9.2026
Yahoo · 17.9.2026
Yahoo · 17.9.2026
ChartMill · 16.9.2026
Benzinga · 16.9.2026
ChartMill · 15.9.2026
ChartMill · 15.9.2026
Yahoo · 15.9.2026
Investor's Business Daily · 15.9.2026
Simply Wall St. · 14.9.2026
Yahoo · 14.9.2026
ChartMill · 14.9.2026
Travelers Companies (The) (TRV) currently has a StockIQ AI score of 71/100, rated "Strong". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
TRV currently scores 71/100 (Strong) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
TRV's technical score is 87/100, which currently reads as bullish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Earnings per share (EPS) growth: 27.8%; Net income growth: 25.8%; ATR: 1.8% of price.
Based on the real signals StockIQ computed: Return on assets (ROA): 4.4% — weak.
Yes — TRV has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 12 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| OLIVO MARIA | Open Market Sale | 28.8.2026 | 118,742 | -6,000 | $369.86 |
| OLIVO MARIA | Open Market Sale | 28.8.2026 | 6,000 | -6,000 | $369.86 |
| Jabbour Anthony M | Grant/Award from Employer | 14.8.2026 | 446 | +446 | $370.36 |
| Kurtzman Diane | Exercise of Derivative Securities | 24.7.2026 | 4,164 | -4,164 | — |
| Kurtzman Diane | Open Market Sale | 24.7.2026 | 4,164 | -4,164 | $386.71 |
| Yin Daniel Tei-Hwa | Open Market Sale | 24.7.2026 | 7,153 | -7,153 | $387.00 |
| Yin Daniel Tei-Hwa | Exercise of Derivative Securities | 24.7.2026 | 7,153 | -7,153 | — |
| Kurtzman Diane | Exercise of Derivative Securities | 24.7.2026 | 4,164 | +4,164 | $132.58 |
| Yin Daniel Tei-Hwa | Exercise of Derivative Securities | 24.7.2026 | 7,153 | +7,153 | $140.85 |
| Kurtzman Diane | Exercise of Derivative Securities | 24.7.2026 | 9,462 | +4,164 | $132.58 |
| Kurtzman Diane | Open Market Sale | 24.7.2026 | 5,298 | -4,164 | $386.71 |
| Kurtzman Diane | Exercise of Derivative Securities | 24.7.2026 | 0 | -4,164 | — |
| Yin Daniel Tei-Hwa | Exercise of Derivative Securities | 24.7.2026 | 75,987 | +7,153 | $140.85 |
| Yin Daniel Tei-Hwa | Open Market Sale | 24.7.2026 | 68,834 | -7,153 | $387.00 |
| Yin Daniel Tei-Hwa | Exercise of Derivative Securities | 24.7.2026 | 0 | -7,153 | — |
| BESSETTE ANDY F | Open Market Sale | 22.7.2026 | 100 | -100 | $368.87 |
| Munson Paul E. | Exercise of Derivative Securities | 22.7.2026 | 1,525 | -1,525 | — |
| BESSETTE ANDY F | Open Market Sale | 22.7.2026 | 2,900 | -2,900 | $368.09 |
| Munson Paul E. | Exercise of Derivative Securities | 22.7.2026 | 1,525 | +1,525 | $126.18 |
| Munson Paul E. | Open Market Sale | 22.7.2026 | 1,525 | -1,525 | $369.91 |
| Rowland David Donnay | Exercise of Derivative Securities | 22.7.2026 | 5,000 | -5,000 | — |
| Rowland David Donnay | Open Market Sale | 22.7.2026 | 5,000 | -5,000 | $371.69 |
| Rowland David Donnay | Exercise of Derivative Securities | 22.7.2026 | 5,000 | +5,000 | $132.58 |
| BESSETTE ANDY F | Open Market Sale | 22.7.2026 | 21,384 | -2,900 | $368.09 |
| BESSETTE ANDY F | Open Market Sale | 22.7.2026 | 21,284 | -100 | $368.87 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
5,720,751 shares short as of 2026-08-31 · vs. 7,439,548 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
64.3% of trading volume this week was short selling, vs. 57.5% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology